Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.
AUTOR(ES)
Shinotoh, H
RESUMO
Striatal dopamine D1 receptors were investigated in 11 patients with Parkinson's disease (PD), five patients with striatonigral degeneration (SND) and six age-matched controls by positron emission tomography and carbon-11 labelled SCH23390. The SND patients showed mean 12%, 21%, and 31% declines in the ratios of radioactivity in the caudate, anterior putamen, and posterior putamen compared with that in the occipital cortex. These ratios were not significantly altered in the PD patients. The results may explain the different therapeutic responses to levadopa between SND and PD patients, and this technique might prove useful for their differentiation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1015002Documentos Relacionados
- Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
- Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
- Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study
- The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
- Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study.